Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.026 | 0.6 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.067 | 0.7 |
mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |